Subtype
Malignant Reproductive System Neoplasm
CI-CAN-00001172Explore in graph →
2,803 active trials38 approved drugs186 evidence items
- NCIt
- C36076
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001172Explore in graph →
Clinical trials
12,155 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,473)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03297489 | Intravital Microscopy in Evaluating Patients With Primary Peritoneal, Fallopian Tube, or Stage IA-IV Ovarian Cancer | completed | Early Phase 1 | 19 | Roswell Park Cancer InstituteOTHER | 1 | Oct 6, 2021 | clinicaltrials |
| NCT01434342 | Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients | completed | Early Phase 1 | 146 | Wake Forest University Health SciencesOTHER | 1 | Sep 28, 2021 | clinicaltrials |
| NCT02420665 | Use of High-Resolution Microendoscopy (HRME) in Patients With Cervical Dysplasia | completed | Early Phase 1 | 50 | M.D. Anderson Cancer CenterOTHER | 1 | May 28, 2021 | clinicaltrials |
| NCT04060043 | Pilot Study to Evaluate the Effects of a Generic Goserelin Acetate in Patients With Prostate Cancer | completed | Early Phase 1 | 11 | CMX ResearchOTHER | 2 | May 10, 2021 | clinicaltrials |
| NCT04282824 | Impact of Monosodium Glutamate on 68GA-PSMA-11, PET Imaging Biodistribution in Patients With Prostate Cancer(MSG PSMA PET) | completed | Early Phase 1 | 14 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Dec 2, 2020 | clinicaltrials |
| NCT02357121 | Focal Laser Ablation of Prostate Tissue(FLA) | completed | Early Phase 1 | 11 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Sep 21, 2020 | clinicaltrials |
| NCT04461457 | Targeted Radiation Therapy for Ovarian Cancer: Intraperitoneal Treatment With 211-astatine-MX35 F(ab')2 | completed | Early Phase 1 | 12 | Vastra Gotaland RegionOTHER_GOV | 1 | Jul 8, 2020 | clinicaltrials |
| NCT02767362 | A Pre-Op Window Study Evaluating Anti-Proliferative Effects of Atorvastatin on the Endometrium | completed | Early Phase 1 | 24 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Jul 7, 2020 | clinicaltrials |
| NCT01670799 | Availability & Effect of Post-OP Ketorolac on Ovarian, Fallopian Tube or Primary Peritoneal Cancer | completed | Early Phase 1 | 29 | New Mexico Cancer Research AllianceOTHER | 1 | Feb 27, 2020 | clinicaltrials |
| NCT01705288 | Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study | completed | Early Phase 1 | 103 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Feb 17, 2020 | clinicaltrials |
| NCT01504126 | Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | completed | Early Phase 1 | 32 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 29, 2019 | clinicaltrials |
| NCT01747798 | Auranofin in Treating Patients With Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | completed | Early Phase 1 | 10 | Mayo ClinicOTHER | 1 | Aug 2, 2019 | clinicaltrials |
| NCT00214422 | Intensity Modulated Radiation Therapy for Prostate Cancer | completed | Early Phase 1 | 19 | National Cancer Institute (NCI)NIH | 1 | Jul 19, 2019 | clinicaltrials |
| NCT02646319 | Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations | completed | Early Phase 1 | 2 | Mayo ClinicOTHER | 1 | Jun 6, 2019 | clinicaltrials |
| NCT02190279 | 18F-DCFBC PET/CT in Prostate Cancer | completed | Early Phase 1 | 116 | National Cancer Institute (NCI)NIH | 1 | Apr 23, 2019 | clinicaltrials |
| NCT00662233 | Combination Chemotherapy in Treating Patients With Sarcoma | completed | Early Phase 1 | 28 | Mayo ClinicOTHER | 1 | Oct 9, 2018 | clinicaltrials |
| NCT02115828 | A Study of Vismodegib in Men With Metastatic CRPC With Accessible Metastatic Lesions for Tumor Biopsy | completed | Early Phase 1 | 9 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jul 20, 2018 | clinicaltrials |
| NCT01132014 | Autologous OC-DC Vaccine in Ovarian Cancer | completed | Early Phase 1 | 67 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jun 11, 2018 | clinicaltrials |
| NCT01992718 | What Are we Missing? Diagnosing Uterine Adenomyosis Using Ultrasound Elastography | completed | Early Phase 1 | 49 | University of MichiganOTHER | 1 | May 31, 2018 | clinicaltrials |
| NCT01205672 | Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer | completed | Early Phase 1 | 21 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 2, 2017 | clinicaltrials |
| NCT02033447 | Magnetic Nanoparticle Thermoablation-Retention and Maintenance in the Prostate:A Phase 0 Study in Men(MAGNABLATE I) | completed | Early Phase 1 | 12 | University College London HospitalsOTHER | 1 | May 10, 2017 | clinicaltrials |
| NCT01050842 | Bicalutamide and Raloxifene in Treating Patients With Metastatic or Hormone-Refractory Prostate Cancer | completed | Early Phase 1 | 18 | Mayo ClinicOTHER | 1 | Mar 23, 2017 | clinicaltrials |
| NCT02546752 | Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine | completed | Early Phase 1 | 1,306 | Regenstrief Institute, Inc.OTHER | 1 | May 25, 2016 | clinicaltrials |
| NCT01482728 | Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer | completed | Early Phase 1 | 12 | University of VirginiaOTHER | 1 | May 13, 2016 | clinicaltrials |
| NCT01626014 | Interactive Educational Website for Women With Ovarian Cancer & Caregivers | completed | Early Phase 1 | 53 | University of MinnesotaOTHER | 1 | Dec 2, 2015 | clinicaltrials |
| NCT01959477 | Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant | completed | Early Phase 1 | 33 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 13, 2015 | clinicaltrials |
| NCT02139371 | Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography | completed | Early Phase 1 | 10 | Rigshospitalet, DenmarkOTHER | 1 | Dec 12, 2014 | clinicaltrials |
| NCT01588301 | Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention(APACHE-2) | completed | Early Phase 1 | 5,998 | University Hospital, ToursOTHER | 0 | Sep 12, 2014 | clinicaltrials |
| NCT00956163 | Whole Body Fluorine F 18 Sodium Fluoride PET/CT Scan and Whole Body MRI in Finding Bone Metastases in Patients With Prostate Cancer | completed | Early Phase 1 | 50 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2014 | clinicaltrials |
| NCT01911247 | Preoperative Window Study of Metformin for the Treatment of Endometrial Cancer | completed | Early Phase 1 | 28 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Jul 30, 2013 | clinicaltrials |
| NCT00436410 | Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer | completed | Early Phase 1 | 108 | National Institutes of Health Clinical Center (CC)NIH | 1 | May 2, 2012 | clinicaltrials |
| NCT00620243 | Pilot Study to Evaluate 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography /Computed Tomography (PET/CT) in Prediction of Early Response to Chemotherapy in Ovarian Cancer. | completed | Early Phase 1 | 9 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 9, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Oct 6, 2021source: clinicaltrials